Moffitt Cancer Center Leads Discussion on Critical Shortfall in Oncologists

February 13, 2014

WHO:  Moffitt Cancer Center, the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida.

WHAT: Moffitt CEO Alan F. List, M.D. and Center Director Thomas A. Sellers, Ph.D., M.P.H. will have a 30-minute media interview availability in conjunction with the Moffitt Day, an annual event that helps put a human face on the public policy issues related to cancer.

  • Florida has the second highest burden of cancer incidence and death, and population trends signal that the need for cancer care in Florida will grow over the next several decades. 
  •  A new study projects a shortage of more than 4,000 oncologists nationwide by 2020. Moffitt trains more students in oncology than all other Florida institutions combined. This is why continued financial support from the state is crucial.

WHEN: Tuesday, Feb. 18, 12 p.m.

WHERE: Florida State Capitol Building, Third Floor, 400 S. Monroe Street, Tallahassee, Fla. 32399

CONTACT:  Kim Polacek, 813-507-3173, Kim.Polacek@Moffitt.org.

About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the No. 1 cancer hospital in Florida and has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer since 1999. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, Twitter and YouTube.

###